Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
For the quarter ended September 30, 2026, NAPCO reported total revenue of $50.0 million, a slight increase from $49.2 million in the prior year, driven by a 12% growth in service revenue. Net income rose to $13.0 million ($0.36 per diluted share) compared to $12.2 million ($0.34 per diluted share) in the same period last year. The company maintained a strong liquidity position with $123.9 million in cash and cash equivalents.
NAPCO Security Technologies reported record first quarter fiscal 2027 net revenue of $50.0 million, driven by an 11.5% increase in recurring service revenue. The company also declared a quarterly cash dividend of $0.17 per share payable in January 2027. Net income for the quarter rose 6.9% to $13.0 million, or $0.36 per diluted share.
Term
Q1 2027
“Our Fiscal Q1 performance reflects continued positive financial results. We achieved record Q1 revenue of $50.0 million and record Q1 Adjusted EBITDA of $15.5 million, which was bolstered by our recurring service revenue.”
Kevin Buchel, CEO and President
“While equipment revenue declined year-over-year, the decrease was driven by two locking distributors reducing their purchases during the quarter. Importantly, sell-through at both distributors grew year-over-year and strengthened meaningfully on a sequential basis.”
Supernus Pharmaceuticals, Inc. notified Nasdaq of the completion of its merger on November 2, 2026, and requested the suspension and delisting of its common stock. The company intends to deregister its shares and suspend its reporting obligations under the Exchange Act as it will no longer be listed on any national securities exchange.
Apogee Enterprises extended the employment term of CEO and Executive Chair Donald A. Nolan from November 1, 2026, through April 30, 2027, to ensure leadership continuity during the search for a permanent successor. Mr. Nolan will receive an annualized base salary of $925,000, a transition bonus of up to $250,000, and monthly restricted stock unit grants with an annualized target value of $1.75 million.
Ribbon Communications President & CEO Bruce William McClelland Buys $96.2K of Stock
Bruce William McClelland, President & CEO, bought 60,000 shares of Ribbon Communications Inc. at $1.60 a share, worth $96.2K in total on Oct 30, 2026. Shares held after the trade: 2,969,454 (+2.1%).
Adriana Lizzeth Diaz, Chief Audit Officer, bought 1,792 shares of Bladex, Inc. at $52.39 a share, worth $93.9K in total on Oct 30, 2026. Shares held after the trade: 15,090 (+13.5%).
Progressive reported a 4% increase in net premiums written for Q3 2026, with a strong companywide combined ratio of 88.7. The company saw significant growth in its personal property segment and commercial auto quoting activity, while repurchasing over $1.5 billion in common shares year-to-date.
Cullen/Frost Bankers GEVP Research & Strategy Bobby Berman Sells $378K of Stock
Bobby Berman, GEVP Research & Strategy, sold 2,406 shares of Cullen/Frost Bankers, Inc. at $157.10 a share, worth $378K in total on Oct 30, 2026. Shares held after the trade: 28,406 (-7.8%).
Abvc Biopharma $4.11M Debt Financing with WallachBeth Capital, LLC
ABVC BioPharma entered into a securities purchase agreement for the sale of original issue discount senior convertible promissory notes in an aggregate principal amount of $4,106,060. The notes carry a 17.5% original issue discount, generating gross proceeds of $3.39 million, and mature on June 30, 2027. Proceeds will be used for working capital and to fund a $625,000 settlement payment to Lind Global Fund II LP.
FirstCash Holdings, Inc. has furnished its November 2026 investor presentation deck, which outlines the company's business strategy and financial outlook. The presentation includes updates on its previously announced acquisition of Ramsdens Holdings PLC and general operations in the U.S., Latin America, and the U.K.
Krystal Biotech delivered strong Q3 revenue growth of 30% and profitability, though clinical timelines for several pipeline programs were pushed to 2027, prompting a $400 million share repurchase authorization.
Kenvue Inc. completed its merger with Kimberly-Clark Corporation, with Kenvue surviving as a direct wholly owned subsidiary of Kimberly-Clark. Under the terms of the agreement, Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue common stock held. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit facility and its existing long-term incentive plans.
Supernus Pharmaceuticals M&A Deal with Indivior Pharmaceuticals, Inc.
Supernus Pharmaceuticals completed its previously announced merger with Indivior Pharmaceuticals, with Supernus becoming a wholly owned subsidiary of the combined entity, which has been renamed Supernus, Inc. Supernus stockholders received 1.5401 shares of the combined company for each share held, and the transaction was supported by a new $650 million senior secured term loan facility.
Indivior Pharmaceuticals M&A Deal with Supernus Pharmaceuticals, Inc.
Indivior Pharmaceuticals completed its previously announced merger with Supernus Pharmaceuticals, with the combined entity renamed Supernus, Inc. (Nasdaq: SUPN). To fund a $1.0 billion special cash dividend to legacy Indivior stockholders, the company entered into a $650 million senior secured term loan facility with Citibank.
Paula J. Meiler, Senior Vice President and Chief Financial Officer of CSB Bancorp, Inc., has announced her intention to retire effective April 30, 2027. The company has initiated a search for her successor and Meiler will remain in her role until her retirement date to ensure a seamless transition.
QCR Holdings' subsidiary, Cedar Rapids Bank and Trust Company, has entered into a definitive agreement to sell its Community Bank & Trust division to BankIowa. The divestiture includes three branch locations in the Waterloo-Cedar Falls area, involving approximately $140 million in deposits, $29 million in loans, and $153 million in assets under management. The transaction is expected to close in the first quarter of 2027 as part of the company's strategy to optimize resources and focus on high-growth markets.
Karyopharm Therapeutics has filed for voluntary Chapter 11 bankruptcy protection to implement a Restructuring Support Agreement and a planned merger with Ayrmid Ltd. The company secured $55 million in debtor-in-possession (DIP) financing to maintain operations during the court-supervised sale process. Existing equity holders are warned that their common and preferred stock will likely have no value and experience a complete loss.
CBIZ Signs $5B M&A Deal with Grant Thornton Advisors LLC
CBIZ, Inc. has completed its merger with Grant Thornton Advisors LLC, an affiliate of Grant Thornton, in an all-cash transaction with an enterprise value of $5 billion. As a result of the merger, CBIZ became a wholly owned subsidiary of Grant Thornton Advisors and its common stock has ceased trading on the NYSE.
Sports Entertainment Gaming Global Corp (SEGG) reported that its financial results for the first half of 2026 are not directly comparable to prior periods due to the acquisition of Veloce Media Group in February 2026. Additionally, the company is addressing a legacy $9 million circular transaction scheme from 2020-2021 that requires restatements of several years of historical financial reports.
TE Connectivity announced the retirement of John S. Jenkins, Jr. as Executive Vice President and General Counsel, effective March 31, 2027. Jennifer A. Johnson will succeed him as Executive Vice President and Chief Legal Officer on November 9, 2026, while Mr. Jenkins will remain as an executive legal advisor until his retirement date.
Mid Penn Bank appointed Scott W. Micklewright as Chief Operating Officer and updated his compensation to include a $525,000 base salary and a 5-year employment agreement. The company also adjusted the compensation for CFO Justin T. Webb, setting his base salary at $535,000 with similar contract extensions and supplemental retirement benefits.
Cipher Digital Inc. is transitioning its business model to include high-performance compute (HPC) data center development alongside its historical bitcoin mining operations. As of October 30, 2026, the company reported 456,365,113 shares of common stock outstanding and is classified as a large accelerated filer.
Kimberly-Clark Corporation completed its acquisition of Kenvue Inc. on November 2, 2026, creating a global consumer health and wellness leader with 10 billion-dollar brands. Kenvue shareholders received $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue common stock held.
FG Imperii Acquisition Signs $350M M&A Deal with tZERO Group, Inc.
FG Imperii Acquisition Corp. (FGII) has entered into a definitive merger agreement to acquire tZERO Group, Inc., a leader in tokenization infrastructure, at a pre-money equity valuation of $350 million. Upon closing, the combined company is expected to trade on the NYSE American under the ticker symbol 'TZRO'. The transaction aims to scale tZERO's regulated multi-asset infrastructure-as-a-service solutions and leverage its blockchain patent portfolio.
Value
$350M
Counterparty
tZERO Group, Inc.
“We have talked about the next phase of tZERO’s evolution requiring a more independent footprint. This transaction delivers that objective, unlocks growth paths and strengthens our ability to scale market infrastructure required for an increasingly tokenized financial system.”
Fox Corporation reported a significant increase in total revenues to $4.57 billion for the quarter ended September 30, 2026, compared to $3.74 billion in the prior year period. Net income attributable to stockholders rose to $943 million, or $2.20 per diluted share, driven by strong operational performance and a substantial increase in income before taxes.
Dover Debt Financing Update with The Bank of New York Mellon
Dover Corporation completed a public offering of €800 million in 4.350% Notes due 2030. The notes were issued under a tenth supplemental indenture with The Bank of New York Mellon as trustee and are registered on the New York Stock Exchange.
Bank7 M&A Deal with Century Financial Services Corporation
Bank7 Corp. completed its acquisition of Santa Fe-based Century Financial Services Corporation, the parent company of Century Bank. Century shareholders received a combination of $210.41 in cash and 3.7052 shares of Bank7 common stock per share, while non-accredited investors received $426.53 in cash. The merger expands Bank7's footprint into New Mexico and pairs its high-performing bank with Century's core deposit franchise.
Public Service Enterprise Group (PSEG) reported Q3 2026 net income of $376 million, or $0.76 per share, and non-GAAP operating earnings of $1.15 per share. The company reaffirmed its full-year 2026 non-GAAP operating earnings guidance of $4.28 to $4.40 per share. Management highlighted strong operational performance at PSEG Nuclear and successful storm restoration efforts at PSE&G following severe weather.
“PSEG continues to achieve solid operational and financial results, enabling us to deliver reliable utility service and generate the carbon free, base-load generation our customers expect. Our financial results for the third quarter and year-to-date period align with our expectations for the full-year, and we are reaffirming PSEG’s 2026 guidance for non-GAAP Operating Earnings in the range of $4.28 to $4.40 per share.”
Ralph LaRossa, chair, president and CEO of PSEG
“We continue to execute our long-term strategy to grow PSEG’s non-GAAP Operating Earnings by a compound annual rate of 6% to 8% through 2030 while prioritizing customer affordability and maintaining a solid financial position.”
Once Upon a Farm, PBC held a conference call to provide an update on a voluntary product recall of its Tractor Wheels product line following reports of choking incidents. The company disclosed it had $106 million in cash and no debt as of September 30, 2026, while it continues to investigate the root cause of the safety issue with the FDA.